A change in the market—investing in diagnostics

被引：0
|
作者：
Keith Batchelder
Peter Miller
机构：
[1] Genomic Healthcare Strategies,
来源：
Nature Biotechnology | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Low margins, tricky reimbursement issues and the difficulty of market penetration have traditionally made diagnostics unattractive to investors. However, with changes to healthcare economics, regulation and the adoption of companion diagnostic tests that are predictive for drug response, that may be about to change.
引用
收藏
页码：922 / 926
页数：4
相关论文
共 50 条
12345